pamidronate has been researched along with thyroxine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bauss, F; Bosies, E; Fleisch, H; Janner, M; Mühlbauer, RC; Schenk, R; Strein, K | 1 |
Chen, V; Ferguson, L; Garber, J; Greenspan, SL; Lee, K; Lee, SL; Moses, AC; Rosen, HN; Ross, DS | 1 |
Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS | 1 |
Gomez-Acotto, C; Mautalen, C; Zeni, S | 1 |
1 review(s) available for pamidronate and thyroxine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for pamidronate and thyroxine
Article | Year |
---|---|
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate.
Topics: Adult; Analysis of Variance; Antineoplastic Agents; Bone Density; Depression, Chemical; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pamidronate; Thyroid Neoplasms; Thyroxine | 1998 |
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorption; Carcinoma, Papillary; Collagen; Collagen Type I; Creatinine; Diphosphonates; Double-Blind Method; Fasting; Humans; Osteocalcin; Osteolysis; Pamidronate; Peptides; Thyroid Neoplasms; Thyroxine | 1998 |
2 other study(ies) available for pamidronate and thyroxine
Article | Year |
---|---|
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
Topics: Alendronate; Animals; Benzoates; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Ibandronic Acid; Injections, Intravenous; Osteoclasts; Pamidronate; Rats; Retinoids; Risedronic Acid; Spectrophotometry, Atomic; Tetracycline; Thyroxine | 1991 |
Do different aminobisphosphonates have similar preventive effect on experimental thyroid hormone-induced osteopenia in rats?
Topics: Alendronate; Animals; Body Weight; Bone Diseases, Metabolic; Diphosphonates; Female; Pamidronate; Rats; Rats, Sprague-Dawley; Thyroxine | 2001 |